{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:45:32Z","timestamp":1789667132466,"version":"4.0.1"},"reference-count":21,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2026.05743","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:56:27Z","timestamp":1778676987000},"source":"Crossref","is-referenced-by-count":2,"title":["Is CMV PCR Monitoring Necessary for Hematological Malignancy During Chemotherapy? A Prospective Single-Center Study"],"prefix":"10.4274","author":[{"given":"Zeynep Tu\u011fba","family":"Karabulut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevfik","family":"D\u00fcndar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhat","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer","family":"Keklik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"G\u00f6kahmeto\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leylag\u00fcl","family":"Kaynar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3389\/fmicb.2020.02104","article-title":"Functional profile of human cytomegalovirus genes and their associated diseases: a review","volume":"11","author":"Ye","year":"2020","unstructured":"1. Ye L, Qian Y, Yu W, Guo G, Wang H, Xue X. Functional profile of human cytomegalovirus genes and their associated diseases: a review. Front Microbiol. 2020;11:2104.","journal-title":"Front Microbiol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"703256","DOI":"10.3389\/fimmu.2021.703256","article-title":"Cytomegalovirus in haematolog-ical tumours","volume":"12","author":"Alonso-\u00c1lvarez","year":"2021","unstructured":"2. Alonso-\u00c1lvarez S, Colado E, Moro-Garc\u00eda MA, Alonso-Arias R. Cytomegalovirus in haematolog-ical tumours. Front Immunol. 2021;12:703256.","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00277-016-2831-7","article-title":"Cyto-megalovirus infection in patients with haematological diseases and after autologous stem cell transplantation as consolidation: a single-centre study","volume":"96","author":"Piukovics","year":"2017","unstructured":"3. Piukovics K, Terhes G, Gurbity-P\u00e1lfi T, Bereczki \u00c1, R\u00e1rosi F, De\u00e1k J, Borb\u00e9nyi Z, Urb\u00e1n E. Cyto-megalovirus infection in patients with haematological diseases and after autologous stem cell transplantation as consolidation: a single-centre study. Ann Hematol. 2017;96:125-131.","journal-title":"Ann Hematol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recip-ients","volume":"25","author":"Ljungman","year":"2011","unstructured":"4. Ljungman P, Hakki M, Boeckh M. Cytomegalovirus in hematopoietic stem cell transplant recip-ients. Hematol Oncol Clin North Am. 2011;25:151-169.","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/hon.2453","article-title":"Cytomegalovirus infection in hematologic ma-lignancy settings other than the allogeneic transplant","volume":"36","author":"Marchesi","year":"2018","unstructured":"5. Marchesi F, Pimpinelli F, Ensoli F, Mengarelli A. Cytomegalovirus infection in hematologic ma-lignancy settings other than the allogeneic transplant. Hematol Oncol. 2018;36:381-391.","journal-title":"Hematol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3816\/CLM.2006.n.016","article-title":"Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality","volume":"6","author":"Torres","year":"2006","unstructured":"6. Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma. 2006;6:393-398.","journal-title":"Clin Lymphoma Myeloma"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/jmv.21779","article-title":"Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia","volume":"82","author":"Capria","year":"2010","unstructured":"7. Capria S, Gentile G, Capobianchi A, Cardarelli L, Gianfelici V, Trisolini SM, Fo\u00e0 R, Martino P, Meloni G. Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia. J Med Virol. 2010;82:1201-1207.","journal-title":"J Med Virol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/ejh.12551","article-title":"Cytomegalovirus reactivation in patients with multiple myeloma","volume":"96","author":"Hasegawa","year":"2016","unstructured":"8. Hasegawa T, Aisa Y, Shimazaki K, Ito C, Nakazato T. Cytomegalovirus reactivation in patients with multiple myeloma. Eur J Haematol. 2016;96:78-82.","journal-title":"Eur J Haematol"},{"key":"ref8","unstructured":"9. Chang H, Tang TC, Hung YS, Lin TL, Kuo MC, Wang PN. Cytomegalovirus infection in non-transplant patients with hematologic neoplasms: a case series. Chang Gung Med J. 2011;34:65-74."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","unstructured":"10. Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths PD; Disease Definitions Working Group of the Cytomegalovirus Drug Devel-opment Forum. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017;64:87-91.","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3389\/fmicb.2019.01186","article-title":"Human cytomegal-ovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients","volume":"10","author":"Stern","year":"2019","unstructured":"11. Stern L, Withers B, Avdic S, Gottlieb D, Abendroth A, Blyth E, Slobedman B. Human cytomegal-ovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients. Front Microbiol. 2019;10:1186.","journal-title":"Front Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Hakimi Z, Ferchichi S, Aballea S, Odeyemi I, Toumi M, English M, Yakoub-Agha I. Burden of cy-tomegalovirus disease in allogeneic hematopoietic cell transplant recipients: a national, matched cohort study in an inpatient setting. Curr Res Transl Med. 2018;66:95-101.","DOI":"10.1016\/j.retram.2018.08.004"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1399-3062.2010.00504.x","article-title":"Pre-transplant cytomegalovirus (CMV) serostatus remains the most important deter-minant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy","volume":"12","author":"George","year":"2010","unstructured":"13. George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Brad-stock K. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important deter-minant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transpl Infect Dis. 2010;12:322-329.","journal-title":"Transpl Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/10428194.2013.798867","article-title":"Cytomegalovirus infection and end-organ dis-ease in Asian patients with lymphoma receiving chemotherapy","volume":"55","author":"Tay","year":"2014","unstructured":"14. Tay MR, Lim ST, Tao M, Quek RH, Tay K, Tan TT. Cytomegalovirus infection and end-organ dis-ease in Asian patients with lymphoma receiving chemotherapy. Leuk Lymphoma. 2014;55:182-187.","journal-title":"Leuk Lymphoma"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1111\/imj.15496","article-title":"Cy-tomegalovirus DNAemia and disease: current-era epidemiology, clinical characteristics and outcomes in cancer patients other than allogeneic haemopoietic transplantation","volume":"52","author":"Tay","year":"2022","unstructured":"15. Tay KH, Slavin MA, Thursky KA, Coussement J, Worth LJ, Teh BW, Khot A, Tam CS, Yong MK. Cy-tomegalovirus DNAemia and disease: current-era epidemiology, clinical characteristics and outcomes in cancer patients other than allogeneic haemopoietic transplantation. Intern Med J. 2022;52:1759-1767.","journal-title":"Intern Med J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1128\/JCM.01670-06","article-title":"Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer","volume":"45","author":"Han","year":"2007","unstructured":"16. Han XY. Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer. J Clin Microbiol. 2007;45:1126-1132.","journal-title":"J Clin Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Phasuk N, Keatkla J, Rattanasiri S, Techasaensiri C, Anurathapan U, Apiwattanakul N. Monitor-ing of cytomegalovirus infection in non-transplant pediatric acute lymphoblastic leukemia pa-tients during chemotherapy. Medicine (Baltimore). 2019;98:e14256.","DOI":"10.1097\/MD.0000000000014256"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.1002\/cam4.4269","article-title":"Cytomegalovirus reactivation in esophageal cancer patients receiving chemoradiotherapy: a retrospective analysis","volume":"10","author":"Kitagawa","year":"2021","unstructured":"18. Kitagawa K, Okada H, Miyazaki S, Funakoshi Y, Sanada Y, Chayahara N, Mayahara H, Fujii M. Cytomegalovirus reactivation in esophageal cancer patients receiving chemoradiotherapy: a retrospective analysis. Cancer Med. 2021;10:7525-7533.","journal-title":"Cancer Med"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Anderson-Smits C, Baker ER, Hirji I. Coinfection rates and clinical outcome data for cytomeg-alovirus and Epstein-Barr virus in post-transplant patients: a systematic review of the literature. Transpl Infect Dis. 2020;22:e13396.","DOI":"10.1111\/tid.13396"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Kelesidis T, Daikos G, Boumpas D, Tsiodras S. Does rituximab increase the incidence of infec-tious complications? A narrative review. Int J Infect Dis. 2011;15:e2-16.","DOI":"10.1016\/j.ijid.2010.03.025"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1515\/med-2021-0274","article-title":"Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens","volume":"16","author":"Pezzullo","year":"2021","unstructured":"21. Pezzullo L, Giudice V, Serio B, Fontana R, Guariglia R, Martorelli MC, Ferrara I, Mettivier L, Bru-no A, Bianco R, Vaccaro E, Pagliano P, Montuori N, Filippelli A, Selleri C. Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens. Open Med (Wars). 2021;16:672-682.","journal-title":"Open Med (Wars)"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:32:53Z","timestamp":1789626773000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z5\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-05743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":21,"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2026.05743","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]}}}